European Organisation for Research and Treatment of Cancer
EORTC aims ultimately to increase people’s survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery, and radiotherapy. EORTC also helps develop new drugs and approaches in partnership with the pharmaceutical industry and in patients’ best interests.
Content by European Organisation for Research and Treatment of Cancer
Updated |3 min read
Postsurgery Immunotherapy Doesn’t Improve Survival in Breast Cancer
Adding atezolizumab immunotherapy to postsurgery chemotherapy doesn’t have the same benefits as the pre-surgery regimenPage 1 of 1




